Analysis of ERBB4 mutations and expression in Japanese patients with lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 11, 2010, Pages 1859-1861

  Tomizawa, Kenji ^a,b   Suda, Kenichi ^a   Onozato, Ryoichi ^b   Kuwano, Hiroyuki ^b   Yatabe, Yasushi ^a   Mitsudomi, Tetsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

ERBB4 mutation; Expression; Extracellular domain; Lung cancer; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; JAPANESE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 78149457015     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f1c433     Document Type: Article

References (13)

1. Olayioye MA, Neve RM, Lane HA, et al. The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J 2000; 19:3159-3167.
2. Soung YH, Lee JW, Kim SY, et al. Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer 2006;118:1426-1429.
3. Sasaki H, Okuda K, Kawano O, et al. ErbB4 expression and mutation in Japanese patients with lung cancer. Clin Lung Cancer 2007;8:429-433.
4. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075.
5. Burgess AW, Cho HS, Eigenbrot C, et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 2003;12:541-552.
6. Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923.
7. Onozato R, Kosaka T, Kuwano H, et al. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J Thorac Oncol 2009;4:5-11.
8. Lee JC, Vivanco I, Beroukhim R, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med 2006;3:e485.
9. Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003;21:3798-3807.
10. Jeon YK, Sung SW, Chung JH, et al. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer 2006;54:387-398.
11. Onn A, Correa AM, Gilcrease M, et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 2004;10:136-143.
12. Muller-Tidow C, Diederichs S, Bulk E, et al. Identification of metastasis- associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 2005;65:1778-1782.
13. Starr A, Greif J, Vexler A, et al. ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer 2006;119:269-274.